Harmony Biosciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation

Harmony Biosciences released its Q4 2025 earnings presentation, detailing financial performance and strategic updates during its February 2026 earnings call. The slide deck accompanied the company’s quarterly results, offering investors and analysts visual insights into revenue growth, pipeline progress, and operational milestones. Key focus areas included commercial performance of lead products, R&D advancements, and market expansion strategies, reflecting the company’s biopharmaceutical priorities. No specific financial figures were disclosed in the transcript preview, but the presentation likely addressed year-over-year comparisons and 2026 outlook. The earnings call underscored Harmony’s commitment to transparency, with the slide deck serving as a supplementary resource for stakeholders.